Institute of Cancer Research, London | United Kingdom
Our group is working on cancer-associated chromosomal translocation protein products and using antibody fragments to interfere with function in vivo. The aim is to develop an intracellular immunotherapy platform for cancer treatment.
Keywords: Molecular biology of leukemia / chromosomal translocations / haematopoiesis / experimental therapeutics / cancer biology / LMO2
Subject area(s): Proteins & Biochemistry | Molecular Medicine | Immunology